Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Anomalous RT dose linked to lower survival in uterine cancer

Publish date:: May 17, 2019

Key clinical point: Anomalies in radiation therapy dose linked to lower survival in uterine cancer.

Major finding: Anomalous radiation therapy doses are associated with a 6.7-percentage-point lower overall survival in women with uterine cancer.

Study details: Analysis of radiation therapy data from 14,298 women with uterine cancer.

Disclosures: One author was an employee of Bioventus, and three declared research funding from the pharmaceutical sector. No other conflicts of interest were declared.

Citation:

Jacobs C et al. JCO Clin Cancer Inform. 2019 May 3. doi: 10.1200/CCI.18.00118.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Gynecologic Cancer

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

Is diagnostic hysteroscopy safe in patients with type 2 endometrial cancer?,

Cervical cancer recurrence patterns differ after laparoscopic and open hysterectomy,

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest,

Half of women treated for gynecologic cancers miss or skip doses of oral drugs,